Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway
2022 · Pharmacological Research · 81 citations
https://doi.org/10.1016/j.phrs.2022.106092
C
Cheng Tian
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
1.5K
Citations
12
h-index
12
i10-index
Cheng Tian is an academic researcher from Shanghai University. The author has contributed to research in topics: COVID-19 Clinical Research Studies & SARS-CoV-2 and COVID-19 Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 12, co-authored 49 publications.
ORCID: 0000-0003-4046-2288Papers by this author
worksThe combination of gemcitabine and ginsenoside Rh2 enhances the immune function of dendritic cells against pancreatic cancer via the CARD9-BCL10-MALT1 / NF-κB pathway
2022 · Clinical Immunology · 21 citations
https://doi.org/10.1016/j.clim.2022.109217
Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives
2024 · Archives of Toxicology · 3 citations
https://doi.org/10.1007/s00204-024-03950-9
Lactate/albumin ratio as a prognostic biomarker for in-hospital mortality in pediatric patients with necrotizing enterocolitis
2025 · BMC Pediatrics · 2 citations
https://doi.org/10.1186/s12887-025-05439-5
Targeting CD70 Enhances Radiosensitivity and Modulates Immune Microenvironment in Non-Small Cell Lung Cancer
2025 · International Journal of Radiation Oncology*Biology*Physics · 0 citations
https://doi.org/10.1016/j.ijrobp.2025.06.2674
Psychological distress and loneliness among European university students during the COVID-19 pandemic: a European survey
2025 · BMC Public Health · 0 citations
https://doi.org/10.1186/s12889-025-25001-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat